Incyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.

CEO

William J. Meury

CEOWilliam J. Meury

Employees

2,617

Employees2,617

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

1991

Founded1991

Employees

2,617

Employees2,617

INCY Key Statistics

Market cap

17.10B

Market cap17.10B

Price-Earnings ratio

19.83

Price-Earnings ratio19.83

Dividend yield

—

Dividend yield—

Average volume

1.52M

Average volume1.52M

High today

$87.95

High today$87.95

Low today

$85.92

Low today$85.92

Open price

$87.15

Open price$87.15

Volume

1.21M

Volume1.21M

52 Week high

$88.66

52 Week high$88.66

52 Week low

$53.56

52 Week low$53.56

INCY News

Nasdaq 1d

Maze Therapeutics Appoints Hervé Hoppenot As Board Chairman

(RTTNews) - Maze Therapeutics, Inc. (MAZE), Monday announced the appointment of Hervé Hoppenot as Chairman of its Board of Directors. Hoppenot will succeed Cha...

Simply Wall St 4d

Will Incyte's New Strategy Team and CALR Antibody Hopes Reshape Its Long-Term Story?

Incyte recently presented at the 15th World Clinical Biomarkers & CDx Summit in Boston and announced the appointment of Dave Gardner as Executive Vice President...

Analyst ratings

54%

of 28 ratings

Buy

35.7%

Hold

53.6%

Sell

10.7%

People also own

Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.